Page 64 - Orange Book Cumulative Supplement 10 October 2012
P. 64
RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 10 - October 2012 1-54
FOSPHENYTOIN SODIUM
INJECTABLE; INJECTION
FOSPHENYTOIN SODIUM
AP HIKMA MAPLE EQ 50MG PHENYTOIN NA/ML A077989 001 Aug 06, 2007 Jul CAHN
@ TEVA PARENTERAL EQ 50MG PHENYTOIN NA/ML A076886 001 Aug 06, 2007 Mar DISC
FOSPROPOFOL DISODIUM
SOLUTION; INTRAVENOUS
LUSEDRA
@ EISAI INC 1050MG/30ML (35MG/ML) N022244 001 Dec 12, 2008 Jul DISC
FUROSEMIDE
INJECTABLE; INJECTION
FUROSEMIDE
@ HIKMA MAPLE 10MG/ML A071439 001 Sep 14, 1990 Sep CAHN
@ 10MG/ML N018267 001 Sep CAHN
@ HOSPIRA 10MG/ML A070578 001 Jul 08, 1987 Jun DISC
GABAPENTIN
SOLUTION; ORAL
GABAPENTIN
AA ACELLA PHARMS LLC 250MG/5ML A076403 001 May 01, 2012 Jun CAHN
AA AMNEAL PHARMS 250MG/5ML A202024 001 Mar 23, 2012 Mar NEWA
AA KIEL 250MG/5ML A076403 001 May 01, 2012 Apr NEWA
TABLET; ORAL
GABAPENTIN
>A> AB INVAGEN PHARMS 600MG A202764 001 Oct 16, 2012 Oct NEWA
>A> AB 800MG A202764 002 Oct 16, 2012 Oct NEWA
AB MYLAN PHARMS INC 600MG A090335 001 Jun 01, 2010 Sep CAHN
AB 800MG A090335 002 Jun 01, 2010 Sep CAHN
GANCICLOVIR
CAPSULE; ORAL
GANCICLOVIR
@ RANBAXY LABS LTD 250MG A076457 001 Jun 27, 2003 Apr DISC
@ 500MG A076457 002 Jun 27, 2003 Apr DISC
GEMCITABINE HYDROCHLORIDE
INJECTABLE; INJECTION
GEMCITABINE HYDROCHLORIDE
AP EMCURE PHARMS LTD EQ 200MG BASE/VIAL A202063 001 Sep 11, 2012 Aug NEWA
AP EQ 1GM BASE/VIAL A202063 002 Sep 11, 2012 Aug NEWA
AP HAMELN RDS GMBH EQ 200MG BASE/VIAL A090663 001 Sep 10, 2012 Aug NEWA
AP EQ 1GM BASE/VIAL A090663 002 Sep 10, 2012 Aug NEWA
+ HOSPIRA INC 200MG/5.26ML (38MG/ML) N200795 001 Aug 04, 2011 Apr CTNA
+ 1GM/26.3ML (38MG/ML) N200795 002 Aug 04, 2011 Apr CTNA
+ 2GM/52.6ML (38MG/ML) N200795 003 Aug 04, 2011 Apr CTNA
>D> AP TEVA PARENTERAL EQ 200MG BASE/VIAL A077983 002 Jan 25, 2011 Oct CAHN
>D> AP EQ 1GM BASE/VIAL A077983 001 Jan 25, 2011 Oct CAHN
>A> AP TEVA PHARMS EQ 200MG BASE/VIAL A077983 002 Jan 25, 2011 Oct CAHN
>A> AP EQ 1GM BASE/VIAL A077983 001 Jan 25, 2011 Oct CAHN